SM
WVE icon

Sabby Management’s Wave Life Sciences WVE Stock Holding History

Sabby Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-75,000
Closed -$1.63M – 186
2017
Q3 		$1.63M Sell
75,000
-66,700
-47% -$1.34M 0.11% 60
2017
Q2 		$2.64M Buy
+141,700
New +$3.05M 0.17% 60

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sabby Management's WVE Position: Q4 2017 in Review

Sabby Management sold out of Wave Life Sciences (WVE) in Q4 2017, closing a stake of 75,000 shares — an estimated $1.63M sold.

Sabby Management first reported a position in WVE in Q2 2017 and held it in 2 quarters. The position peaked at $2.64M in Q2 2017. 73 funds tracked by Wall St. Rank hold WVE as of Q4 2017.

  • Sabby Management reported no remaining Wave Life Sciences position as of Q4 2017 after selling out during the quarter.
  • Sabby Management sold 75,000 Wave Life Sciences shares in Q4 2017, an estimated $1.63M.
  • Sabby Management first reported a position in Wave Life Sciences in Q2 2017 and held it in 2 quarters.
  • Sabby Management's Wave Life Sciences position peaked at $2.64M in Q2 2017.
  • 73 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2017.

Based on Sabby Management's 13F filing for Q4 2017, filed 14 Feb 2018.